orlistat in obese type II diabetics
Last reviewed 01/2018
391 obese type II diabetic patients were recruited to a randomised, double-bind, placebo-controlled trial of orlistat versus placebo.
Patients were clinically stable on sulphonylurea tablet treatment.
References:
- 1) Hollander, PA, Elbein, SC, Hirsch, IB et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care, 1998, 21, 1288-94.